Home » Taro Receives FDA Approval for Levetiracetam Oral Solution
Taro Receives FDA Approval for Levetiracetam Oral Solution
Taro Pharmaceutical Industries Ltd. reported that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Levetiracetam Oral Solution, 100 mg/mL ("levetiracetam oral solution").
MSNBC
MSNBC
Upcoming Events
-
07May
-
14May
-
30May